[go: up one dir, main page]

DE60326773D1 - Peptid-deformylase-hemmer - Google Patents

Peptid-deformylase-hemmer

Info

Publication number
DE60326773D1
DE60326773D1 DE60326773T DE60326773T DE60326773D1 DE 60326773 D1 DE60326773 D1 DE 60326773D1 DE 60326773 T DE60326773 T DE 60326773T DE 60326773 T DE60326773 T DE 60326773T DE 60326773 D1 DE60326773 D1 DE 60326773D1
Authority
DE
Germany
Prior art keywords
peptide deformylase
deformylase inhibitors
inhibitors
peptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326773T
Other languages
English (en)
Inventor
Siegfried B Christensen
Maxwell D Cummings
Jinhwa Lee
Jia-Ning Xiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of DE60326773D1 publication Critical patent/DE60326773D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51Y being a hydrogen or a carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
DE60326773T 2003-04-16 2003-04-16 Peptid-deformylase-hemmer Expired - Lifetime DE60326773D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/011704 WO2004098584A1 (en) 2003-04-16 2003-04-16 Peptide deformylase inhibitors

Publications (1)

Publication Number Publication Date
DE60326773D1 true DE60326773D1 (de) 2009-04-30

Family

ID=33434321

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326773T Expired - Lifetime DE60326773D1 (de) 2003-04-16 2003-04-16 Peptid-deformylase-hemmer

Country Status (8)

Country Link
US (1) US7375120B2 (de)
EP (1) EP1615629B1 (de)
JP (1) JP4373343B2 (de)
AT (1) ATE425962T1 (de)
AU (1) AU2003223634A1 (de)
DE (1) DE60326773D1 (de)
ES (1) ES2322451T3 (de)
WO (1) WO2004098584A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (de) 2005-05-20 2008-01-30 Janssen Pharmaceutica N.V. Verfahren zur herstellung von sulfamidderivaten
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
WO2010008776A2 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
JP2002322197A (ja) 2001-04-24 2002-11-08 Senju Pharmaceut Co Ltd ペプチジルヒドロキサム酸誘導体およびその用途
AU2003248059A1 (en) * 2002-07-22 2004-02-09 Senju Pharmaceutical Co., Ltd. NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF

Also Published As

Publication number Publication date
US20060229341A1 (en) 2006-10-12
ATE425962T1 (de) 2009-04-15
EP1615629A4 (de) 2007-02-28
JP4373343B2 (ja) 2009-11-25
US7375120B2 (en) 2008-05-20
ES2322451T3 (es) 2009-06-22
AU2003223634A1 (en) 2004-11-26
WO2004098584A1 (en) 2004-11-18
EP1615629A1 (de) 2006-01-18
JP2006523612A (ja) 2006-10-19
EP1615629B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
NO20054453D0 (no) P38 inhibitorer og fremgangsmater for anvendelse derav
DK1606283T3 (da) P38-inhibitorer og fremgangsmåder til anvendelse deraf
MY133625A (en) Peptide deformylase inhibitors
UY27192A1 (es) Inhibidores de peptido-deformilasa
DE60326773D1 (de) Peptid-deformylase-hemmer
NO20025281L (no) Peptid-deformylase-inhibitorer
ATE548037T1 (de) Peptid-deformylase-hemmer
WO2004052919A3 (en) Peptide deformylase inhibitors
ATE312077T1 (de) Peptiddeformylase-hemmer
NO20053071L (no) Kalsilytiske forbindelser.
ATE514683T1 (de) Peptid-deformylase-hemmer
WO2005005456A3 (en) Peptide deformylase inhibitors
ATE309984T1 (de) Peptid-deformylase-hemmer
ATE433953T1 (de) Peptiddeformylaseinhibitoren
ATE531690T1 (de) Inhibitoren von peptiddeformylase
WO2007016364A3 (en) Peptide deformylase inhibitors
WO2002070653A3 (en) Peptide deformylase inhibitors
WO2005017124A3 (en) Peptide deformylase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition